title: Epigenetics and the modulation of neuroinflammation.
abstract: Innate immune responses in the central nervous system (CNS) have key roles influencing both physiological and pathological processes. Microglia are innate immune effector cells that reside within the CNS. These inflammatory cells are constantly surveying their external environment and rapidly respond to a variety of molecules that signal changes in CNS homeostasis. In response to these signals, microglia influence neuronal connections, modulate the functions of other glia, and mediate inflammatory responses to disease or injury. In parallel with the regulation of inflammatory responses outside of the CNS, investigators have observed that microglia are capable of heterogeneous responses to exogenous and endogenous signals. While much of this molecular and morphological heterogeneity is regulated by gene transcription, there is ample evidence that microglial behavior is determined, in part, by epigenetic regulation. Recent work has demonstrated that processes involving DNA methylation, histone modification, and noncoding RNAs also have important roles in modulating neuroinflammation. Here I will review the evidence supporting a role for epigenetic regulation of neuroinflammation and describe how this might influence the outcome of several CNS disorders, including addiction, infection, multiple sclerosis, and stroke.
authors: Department of Neurology, University of Washington, Seattle, WA, 98195, USA, gagarden@uw.edu.
authors: Gwenn A
authors: GA
authors: Garden
mesh_terms: D001921:Brain / Q000276:immunology* / Q000473:pathology; D004660:Encephalitis / Q000235:genetics* / Q000276:immunology / Q000473:pathology; D044127:Epigenesis, Genetic; D006801:Humans; D007113:Immunity, Innate; D017628:Microglia / Q000276:immunology* / Q000473:pathology
references: Immunology. 2012 Jan;135(1):73-88
references: 22043967
references: Neuroscience. 2007 Oct 12;149(1):203-12
references: 17850978
references: Mol Med. 2011 May-Jun;17(5-6):442-7
references: 21373721
references: Adv Exp Med Biol. 2013;768:97-126
references: 23224967
references: Glia. 2013 Jan;61(1):91-103
references: 22653784
references: Curr Drug Targets. 2010 Nov;11(11):1430-8
references: 20583972
references: PLoS One. 2012;7(2):e30832
references: 22363497
references: Nat Neurosci. 2007 Dec;10(12):1538-43
references: 18026097
references: FASEB J. 2010 Jul;24(7):2292-300
references: 20181935
references: Psychol Med. 2011 May;41(5):997-1007
references: 20836906
references: J Neuroimmune Pharmacol. 2010 Dec;5(4):521-32
references: 20157787
references: Science. 2011 Sep 9;333(6048):1456-8
references: 21778362
references: Brain Res. 2008 Aug 21;1226:181-91
references: 18582446
references: Curr Top Med Chem. 2009;9(3):309-19
references: 19355993
references: J Neurosci. 2011 Dec 7;31(49):17835-47
references: 22159099
references: Epigenetics. 2006 Apr-Jun;1(2):67-75
references: 17998807
references: FASEB J. 2009 Dec;23(12):4266-75
references: 19723705
references: PLoS One. 2011;6(10):e26317
references: 22046273
references: Br J Pharmacol. 2012 Jan;165(2):494-505
references: 21726209
references: Cell. 2009 Apr 3;137(1):47-59
references: 19345186
references: J Pharmacol Exp Ther. 2007 Jun;321(3):892-901
references: 17371805
references: Nat Med. 2011 Jan;17(1):64-70
references: 21131957
references: J Neurosci. 2013 Mar 20;33(12):5127-37
references: 23516279
references: Science. 2012 Apr 6;336(6077):86-90
references: 22442384
references: J Neuroimmune Pharmacol. 2006 Jun;1(2):127-37
references: 18040779
references: J Neurosci. 2008 Jan 2;28(1):163-76
references: 18171934
references: Glia. 2011 Dec;59(12):1911-22
references: 22170100
references: Life Sci. 2012 Mar 10;90(11-12):463-8
references: 22285595
references: J Neuroimmunol. 2005 Jul;164(1-2):10-21
references: 15885809
references: Glia. 2012 Dec;60(12):1888-95
references: 22907769
references: Curr Mol Med. 2013 May;13(4):640-7
references: 23061676
references: Science. 2010 Nov 5;330(6005):841-5
references: 20966214
references: J Neurosci. 2008 Mar 5;28(10):2576-88
references: 18322101
references: Cytokine Growth Factor Rev. 1997 Dec;8(4):267-92
references: 9620642
references: Neurotoxicology. 2009 Jul;30(4):622-7
references: 19635394
references: Neurobiol Dis. 2011 Oct;44(1):142-51
references: 21757005
references: J Neuroinflammation. 2012 Jun 18;9:131
references: 22709905
references: Nat Neurosci. 2005 Jun;8(6):752-8
references: 15895084
references: Biochem Biophys Res Commun. 2012 Jan 6;417(1):387-92
references: 22166205
references: PLoS One. 2012;7(2):e32662
references: 22393433
references: J Neurosci Res. 2013 May;91(5):694-705
references: 23404572
references: J Neuroimmune Pharmacol. 2009 Dec;4(4):399-418
references: 19655259
references: PLoS One. 2010 Dec 29;5(12):e15743
references: 21206757
references: Neuroreport. 2012 Feb 15;23(3):168-73
references: 22182977
references: Neurosci Lett. 2011 Jul 20;499(2):109-13
references: 21640790
references: J Biol Chem. 2008 Mar 21;283(12):7390-400
references: 18079112
references: Biochem Biophys Res Commun. 1999 Sep 7;262(3):610-4
references: 10471372
references: Stroke. 2013 Jun;44(6):1706-13
references: 23613494
references: RNA Biol. 2012 Mar;9(3):274-82
references: 22336709
references: J Neuroinflammation. 2012 Sep 06;9:211
references: 22950459
references: Neuropathol Appl Neurobiol. 2013 Feb;39(1):3-18
references: 23252647
references: Neurobiol Dis. 2009 Nov;36(2):269-79
references: 19635561
references: Glia. 2011 Oct;59(10):1402-13
references: 21598312
references: Neuron. 2012 May 24;74(4):691-705
references: 22632727